Terns Pharmaceuticals, Inc.
TERN
$52.63
$0.070.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.28% | -7.22% | 4.33% | 0.73% | 1.50% |
| Total Depreciation and Amortization | -44.08% | -33.26% | -24.07% | -7.37% | 1.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.15% | 2.44% | -37.14% | -31.46% | -33.74% |
| Change in Net Operating Assets | -107.33% | 8,792.31% | 169.44% | 163.78% | 197.02% |
| Cash from Operations | -17.37% | -3.92% | 5.87% | 5.47% | -3.90% |
| Capital Expenditure | -- | 100.00% | 100.00% | 83.95% | 19.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,309.79% | -132.79% | -146.73% | 68.13% | 67.40% |
| Cash from Investing | -2,301.64% | -132.82% | -146.79% | 68.15% | 67.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 352.45% | -99.43% | 1,051.05% | 1,044.37% | 288.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 39.43% | -325.33% | -- | -- | -12.79% |
| Cash from Financing | 353.37% | -99.61% | 1,048.29% | 1,041.63% | 290.92% |
| Foreign Exchange rate Adjustments | 128.57% | -125.37% | -111.05% | -132.67% | -147.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 345.71% | -151.43% | 414.99% | 161.99% | 228.75% |